CRTX
Price:
$1.95
Market Cap:
$234.42M
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
NASDAQ
Ticker
CRTX
According to Cortexyme, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.00. This represents a change of -18.79% compared to the average of 6.16 of the last 4 quarters.
The mean historical Current Ratio of Cortexyme, Inc. over the last ten years is 15.83. The current 5.00 Current Ratio has changed 3.06% with respect to the historical average. Over the past ten years (40 quarters), CRTX's Current Ratio was at its highest in in the December 2018 quarter at 49.82. The Current Ratio was at its lowest in in the March 2018 quarter at 0.
Average
15.83
Median
8.10
Minimum
4.28
Maximum
49.82
Discovering the peaks and valleys of Cortexyme, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.07%
Maximum Annual Current Ratio = 49.82
Minimum Annual Increase = -76.06%
Minimum Annual Current Ratio = 4.28
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 6.05 | -25.21% |
| 2023 | 8.09 | -73.52% |
| 2022 | 30.55 | 289.03% |
| 2021 | 7.85 | -3.20% |
| 2020 | 8.11 | -31.99% |
| 2019 | 11.93 | -76.06% |
| 2018 | 49.82 | 1.07% |
The current Current Ratio of Cortexyme, Inc. (CRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.90
5-year avg
12.13
10-year avg
15.83
Cortexyme, Inc.’s Current Ratio is less than Surface Oncology, Inc. (7.94), less than Achilles Therapeutics plc (6.04), less than Landos Biopharma, Inc. (6.09), less than Jade Biosciences, Inc. (9.01), less than Reneo Pharmaceuticals, Inc. (11.13), less than IGM Biosciences, Inc. (17.66), greater than TCR2 Therapeutics Inc. (2.77), less than Kronos Bio, Inc. (12.93), greater than Heat Biologics, Inc. (0.09), greater than Berkeley Lights, Inc. (3.89),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.94 | $65.08M | |
| 6.04 | $60.83M | |
| 6.09 | $71.68M | |
| 9.01 | $488.73M | |
| 11.13 | $60.84M | |
| 17.66 | $77.50M | |
| 2.77 | $58.11M | |
| 12.93 | $53.65M | |
| 0.09 | $61.07M | |
| 3.89 | $86.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cortexyme, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cortexyme, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cortexyme, Inc.'s Current Ratio?
How is the Current Ratio calculated for Cortexyme, Inc. (CRTX)?
What is the highest Current Ratio for Cortexyme, Inc. (CRTX)?
What is the 3-year average Current Ratio for Cortexyme, Inc. (CRTX)?
What is the 5-year average Current Ratio for Cortexyme, Inc. (CRTX)?
How does the current Current Ratio for Cortexyme, Inc. (CRTX) compare to its historical average?